3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
2
Status
Completed
6
Unknown
2
Recruiting
2
Terminated
1
Not yet recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gynecologic
2
Gastrointestinal
1
Conditions
Motor Activity
35
Breast Neoplasms
20
Neoplasms
19
Fatigue
9
Prostatic Neoplasms
4
Lung Neoplasms
4
Hematologic Neoplasms
4
Colorectal Neoplasms
4
Obesity
3
Weight Loss
2
Smoking
2
Sedentary Behavior
2
Postoperative Complications
2
Ovarian Neoplasms
2
Mixed Cancer
2
Lymphedema
2
Frailty
2
Colonic Neoplasms
2
Cardiotoxicity
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Urologic Neoplasms
1
Urinary Incontinence
1
Stomach Neoplasms
1
Sarcoma
1
Risk Reduction Behavior
1
Rehabilitation After Lung Cancer Surgery
1
Interventions
Paclitaxel
35
Carboplatin
35
Bevacizumab
14
olaparib
13
niraparib
11
apatinib
11
Gemcitabine
10
liposomal doxorubicin
9
Hyperthermic Intraperitoneal Chemotherapy
9
Cisplatin
9
pembrolizumab
8
Cyclophosphamide
8
fludarabine
7
Etoposide
7
Topotecan
6
fluzoparib
5
Surveys and Questionnaires
5
Drug Therapy
5
Albumin-Bound Paclitaxel
5
anlotinib
4
Immunohistochemistry
4
Ifosfamide
4
Doxorubicin
4
Docetaxel
4
Cytoreduction Surgical Procedures
4
Taxes
3
Surgical Procedures, Operative
3
Poly(ADP-ribose) Polymerase Inhibitors
3
Neoadjuvant Therapy
3
Laparoscopy
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Unknown
×
Ovarian Neoplasms
×
Exercise
×
Clear all
NCT05305820
2024-03-21
PANO
Dublin City University
Phase NA
Unknown
36 enrolled
NCT05561413
2022-10-03
GEMS
University of Ulster
Phase NA
Unknown
40 enrolled